We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
AUM
$81B
AUM Growth
-$1.58B
Cap. Flow
-$3.65B
Cap. Flow %
-4.5%
Top 10 Hldgs %
16.13%
Holding
1,955
New
98
Increased
953
Reduced
772
Closed
100

Top Sells

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$786M
2
ABEV icon
Ambev
ABEV
+$368M
3
AAPL icon
Apple
AAPL
+$331M
4
BIDU icon
Baidu
BIDU
+$323M
5
JNJ icon
Johnson & Johnson
JNJ
+$285M

Sector Composition

Rank Sector Weight
1 Energy 15.38%
2 Financials 14.63%
3 Consumer Discretionary 13.36%
4 Healthcare 12.27%
5 Technology 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FF icon
1801
Future Fuel
FF
$204M
$213K ﹤0.01%
14,118
+1,155
+9% +$17K
GMED icon
1802
Globus Medical
GMED
$10.4B
$213K ﹤0.01%
6,404
-349
-5% -$11K
TMP icon
1803
Tompkins Financial
TMP
$1.45B
$213K ﹤0.01%
2,710
+44
+2% +$3.54K
COHU icon
1804
Cohu
COHU
$2.39B
$210K ﹤0.01%
13,344
+850
+7% +$15.6K
EGHT icon
1805
8x8 Inc
EGHT
$247M
$210K ﹤0.01%
14,393
+1
+0% +$14
WTRG icon
1806
Essential Utilities
WTRG
$11.2B
$210K ﹤0.01%
6,298
-275
-4% -$9.02K
AHRT
1807
AH Realty Trust
AHRT
$534M
$209K ﹤0.01%
+16,118
New +$221K
FSP
1808
Franklin Street Properties
FSP
$44.8M
$209K ﹤0.01%
18,890
+995
+6% +$11.5K
WT icon
1809
WisdomTree
WT
$2.97B
$208K ﹤0.01%
20,482
-90,966
-82% -$840K
WAFD icon
1810
WaFd
WAFD
$2.72B
$207K ﹤0.01%
6,261
+181
+3% +$6K
MED icon
1811
Medifast
MED
$108M
$206K ﹤0.01%
4,962
+49
+1% +$2.13K
VRE
1812
DELISTED
Veris Residential
VRE
$206K ﹤0.01%
+7,566
New +$207K
WLK icon
1813
Westlake Corp
WLK
$9.46B
$205K ﹤0.01%
3,100
ACC
1814
DELISTED
American Campus Communities, Inc.
ACC
$204K ﹤0.01%
+4,312
New +$205K
BEAT
1815
DELISTED
BioTelemetry, Inc.
BEAT
$204K ﹤0.01%
+6,101
New +$182K
DEI icon
1816
Douglas Emmett
DEI
$2.06B
$203K ﹤0.01%
+5,309
New +$205K
HCI icon
1817
HCI Group
HCI
$2.28B
$202K ﹤0.01%
+4,298
New +$196K
PETS icon
1818
PetMed Express
PETS
$42.5M
$202K ﹤0.01%
+4,975
New +$154K
SCMP
1819
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$202K ﹤0.01%
19,261
+2,821
+17% +$28.8K
IBOC icon
1820
International Bancshares
IBOC
$4.77B
$201K ﹤0.01%
+5,727
New +$202K
GOV
1821
DELISTED
Government Properties Income Trust
GOV
$197K ﹤0.01%
10,794
-1,395
-11% -$30.3K
VTOL icon
1822
Bristow Group
VTOL
$1.35B
$194K ﹤0.01%
10,255
+1,921
+23% +$41K
GIFI
1823
DELISTED
Gulf Island Fabrication
GIFI
$183K ﹤0.01%
15,816
-3,921
-20% -$39.5K
NG icon
1824
NovaGold Resources
NG
$2.6B
$182K ﹤0.01%
40,000
-70,000
-64% -$301K
DHX icon
1825
DHI Group
DHX
$166M
$180K ﹤0.01%
63,127
+25,600
+68% +$84.3K

Similar funds

OppenheimerFunds's Q2 2017 Portfolio in Review

As of Q2 2017, OppenheimerFunds held 1,955 positions worth $81B, down 1.9% from $82.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

OppenheimerFunds withdrew a net $3.65B in Q2 2017, closing 100 positions and reducing 772 holdings. Its most notable exit was Energy Transfer Partners L.p., an estimated $786M position sold in full.

By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, OppenheimerFunds opened a new position in Antero Midstream worth $132M.

  • OppenheimerFunds's largest Q2 2017 buy was Antero Midstream: 5,990,120 shares worth $132M.
  • OppenheimerFunds added most to Energy Transfer Partners, L.P. in Q2 2017, an estimated $729M increase.
  • OppenheimerFunds's biggest Q2 2017 reduction was Apple, cutting an estimated $331M.
  • OppenheimerFunds fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $786M.
  • OppenheimerFunds's ten largest holdings make up 16% of its $81B portfolio in Q2 2017.
  • OppenheimerFunds opened 98 new positions and closed 100 in Q2 2017.
  • OppenheimerFunds's portfolio value fell 1.9% quarter-over-quarter to $81B.

Based on OppenheimerFunds's 13F filing for Q2 2017, filed 14 Aug 2017.